ebook img

LC/IVS/MS PEAKAR PDF

25 Pages·2013·1.98 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview LC/IVS/MS PEAKAR

US 20120322867Al (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0322867 A1 Hughes et al. (43) Pub. Date: Dec. 20, 2012 (54) METHODS OF TREATING AN OVERWEIGHT Dec. 4, 2008, provisional application No. 61/119,891, OR OBESE SUBJECT ?led on Dec. 4, 2008, provisional application No. 61/119,888, ?led on Dec. 4, 2008, provisional appli (76) Inventors: Thomas E- Hughes, Concord, MA (US); cation No. 61/119,891, ?led on Dec. 4, 2008, provi James E-Vath, Lynn?eld, MA (US) sional application No. 61/275,688, ?led on Aug. 3, 2009, provisional application No. 61/260,194, ?led on (21) Appl. No.: 13/568,800 Nov. 11,2009. (22) Filed: Aug. 7, 2012 Publication Classi?cation Related US. Application Data (51) Int- Cl A61K 31/336 (2006.01) (63) Continuation of application No. 13/133,060, ?led on A611) 3/04 (200601) 0“ 27’ 2011’ ?led as aPPllcatlon NO- PCT/US2009/ (52) us. Cl. ..................................................... .. 514/475 066816 on Dec. 4, 2009. (60) Provisional application No. 61/119,881, ?led on Dec. (57) ABSTRACT 4, 2008, provisional application No. 61/119,875, ?led The invention generally relates to methods of treating an on Dec. 4, 2008, provisional application No. 61/ 119, overweight or obese subject, and treating overWeight- or obe 884, ?led on Dec. 4, 2008, provisional application No. sity-related conditions. In certain embodiments, the invention 61/119,886, ?led on Dec. 4, 2008, provisional appli provides a method of treating an overweight or obese subject cation No. 61/119,872, ?led on Dec. 4, 2008, provi including administering a MetAP2 inhibitor in Which the sional application No. 61/119,877, ?led on Dec. 4, amount administered does not substantially modulate angio 2008, provisional application No. 61/119,885, ?led on genesis. TXN(1-4) IN B16F10 CELL LVSATE AFTER CHVMOTRVOTIC DIGESTION 1.0E+O5 - E1 TXN(1-4) 9.0E+04 - 8.0E+04 - 7.0E+O4 - LPAC/ERIVAEIS/KAMS 6.0E+O4 - 5.0E+O4 - 4.0E+O4 - 3.0E+04 - 2.0E+O4 - 1.0E+O4 - 0.0E+00 CONTROL 25 nM FUIVIAGILLIN Patent Application Publication Dec. 20, 2012 Sheet 1 0f 13 US 2012/0322867 A1 TXN(1-4) IN B16F10 CELL LVSATE AFTER CHVIVIOTRVOTIC DIGESTION 1.0E+05— E1 TXN(1-4) 9.0E+04 % < 7.0E+04— LgI)J 5.0E+04 Eg 3.0E+04— 2.0E+04— 1.0E+04— 0.0E+OO CONTROL ' 25nM ' 125nM ' 1000nM FUMAGILLIN FIG. 1 Patent Application Publication Dec. 20, 2012 Sheet 2 0f 13 US 2012/0322867 A1 N-ACETYL TXN(1-4) IN B16F10 CELL LVSATE AFTER CHVMOTRVOTIC DIGESTION 1.0E+04 E N-ACETYL TXN(1-4) 9.0E+03 8.0E+03 111111111 111111111 11111111 11 111 11 11111111 111111111 111 1111 7.0E+03 111111111111111111 1111111111111111 1/ 111 11 11111111 111111111 11111111 LPAC/ERIVAEIS/KAMS 111111111 11111111 111111111 11111111 6.0E+03 111111111 111111111 11111111 11111111 111111111 11111111 111111111 111111111 11111111 111111111 111111111 11111111 111111111 11 111 11 11111111 111111111 111111111 11111111 5.0E+03 111111111 111111111 11111111 111111111 111111111 11111111 1 11111 11 111 11 11111111 111111111 111111111 11111111 1111/1111 111111111 11111111 111111111 111111111 11111111 4.0E+03 111111111 111111111 11111111 111111111 111111111 11111111 111111111 11 111 11 11111111 111111111 111111111 11111111 111111111 111111111 11111111 3.0E+03 111111111111111111 1111 1111111 11111 1111111111111111 111111111 111111111 11111111 111111111 111111111 11111111 111111111 111111111 11111111 1111/1111 11 111 11 11111111 2.0E+03 111111111/11111111 111111111111111111 1111111111111111 111111111 111111111 11111111 111111111 111111111 11111111 111111111 111111111 11111111 111111111 11 111 11 11111111 1.0E+03 111111111111111111 1111 1111111 11111 1111111111111111 111111111 111111111 11111111 111 11111 11 111 11 11111111 111111111 111111111 11111111 11111 111111111 1111111 0.0E+00 111111111 111111111 11111111 CONTROL 25 nM 125 nM 1000 nM FUMAGILLIN FIG. 2 Patent Application Publication Dec. 20, 2012 Sheet 3 0f 13 US 2012/0322867 A1 DN 29/4/09 SH3BGRL+F SHSBGRL .CUS-1+F a-FLAG H2 TXN+F GUS-1 TXN 30sec *N 1 250 — 148- _ 36 — 22 16 FIG. 3 Patent Application Publication Dec. 20, 2012 Sheet 4 0f 13 US 2012/0322867 A1 TRANS 1u0m0 1u0M 1M0M 1MM 600 — 250 — 148— 98— 50 36— 22— 16 — TbN FIG. 4 Patent Application Publication Dec. 20, 2012 Sheet 5 0f 13 US 2012/0322867 A1 (‘l/b3“) awaunamoaam-vua 0 s s s ' ,_ g 5 2‘ E ;_ B» > E’ (m/baw) XXX AiiVzl \ _ _ g oamaaisawow 200-................ I 5 i i | O O 0 0 LO 0 L0 Patent Application Publication Dec. 20, 2012 Sheet 7 0f 13 US 2012/0322867 A1 EPIDIDYIVIAL FAT PERI-RENAL FAT LIVER AGE-IVIATCHED HIGH FAT HIGH FAT LEAN DIET DIET + ZGN 201 FIG. 7 Patent Application Publication Dec. 20, 2012 Sheet 8 0f 13 US 2012/0322867 A1 Ll 00 L9 LL Ir <lr | | LO 00 N C) (6) Cl‘v'd 1w ‘IVEINOLIEIEICIOEILEIEI

Description:
Aug 7, 2012 HIGH FAT. HIGH FAT. LEAN. DIET. DIET +. ZGN 201. FIG. 7 13/133,060 ?led Oct. 27, 201 1, Which is anational stage ?ling Page 24
See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.